Cargando…

Medical Therapy of Active Ulcerative Colitis

BACKGROUND: Medical therapy of mild and moderate ulcerative colitis (UC) of any extent is evidence-based and standardized by national and international guidelines. However, patients with steroid-refractory UC still represent a challenge. METHODS: A literature search using PubMed (search terms: ulcer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bürger, Martin, Schmidt, Carsten, Teich, Niels, Stallmach, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger Verlag für Medizin und Naturwissenschaften GmbH 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608602/ https://www.ncbi.nlm.nih.gov/pubmed/26557831 http://dx.doi.org/10.1159/000436959

Ejemplares similares

Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study
por: Schmidt, Carsten, et al.
Publicado: (2022)

COVID-19 und chronisch-entzündliche Darmerkrankungen
por: Teich, Niels, et al.
Publicado: (2023)

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
por: Teich, Niels, et al.
Publicado: (2022)

Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
por: Bernerth, Karsten, et al.
Publicado: (2018)

Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study
por: Häuser, Winfried, et al.
Publicado: (2005)

Biological therapy for ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2015)

Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results
por: Teich, Niels, et al.
Publicado: (2020)

Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases—LISTEN 1
por: Teich, Niels, et al.
Publicado: (2021)

Adenoma detection rate using narrow-band imaging is inferior to high-definition white light colonoscopy in screening and surveillance colonoscopies in daily clinical care: A randomized controlled trial
por: Bürger, Martin, et al.
Publicado: (2022)

Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Therapie chronisch entzündlicher Darmerkrankungen in der COVID-19-Pandemie
por: Grunert, Philip C., et al.
Publicado: (2020)

Ethanol-based fixation is superior to conventional brush cytology in the evaluation of indeterminate biliary strictures by endoscopic retrograde cholangiography
por: Bürger, Martin, et al.
Publicado: (2020)

The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis
por: LeBlanc, Jean-Frédéric, et al.
Publicado: (2021)

Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey
por: Reuken, Philipp A., et al.
Publicado: (2020)

ULCERATIVE COLITIS
Publicado: (1969)

Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients
por: Quansah, Elsie, et al.
Publicado: (2023)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

Medical consultation in ulcerative colitis: Key elements for improvement
por: González-Lama, Yago, et al.
Publicado: (2023)

Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months
por: Teich, Niels, et al.
Publicado: (2021)

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
por: Feagan, Brian G, et al.
Publicado: (2019)

Have advances in medical therapy for ulcerative colitis impacted surgical treatment?
por: Kuwahara, Ryuichi, et al.
Publicado: (2022)

Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
por: Popov, Jelena, et al.
Publicado: (2021)

Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy
por: Nakase, Hiroshi
Publicado: (2023)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)

Radiographical evaluation of ulcerative colitis
por: Deepak, Parakkal, et al.
Publicado: (2014)

Colonoscopic evaluation in ulcerative colitis
por: Paine, Elizabeth R.
Publicado: (2014)

Histological evaluation in ulcerative colitis
por: DeRoche, Tom C., et al.
Publicado: (2014)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Adherence in ulcerative colitis: an overview
por: Testa, Anna, et al.
Publicado: (2017)

Nutrition and Supplementation in Ulcerative Colitis
por: Radziszewska, Marcelina, et al.
Publicado: (2022)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
por: Sood, Ajit, et al.
Publicado: (2020)

Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
por: Wehkamp, Jan, et al.
Publicado: (2018)

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis
por: Dart, Robin J, et al.
Publicado: (2017)

Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
por: AlAmeel, Turki, et al.
Publicado: (2023)

Ulcerative Colitis—Medical versus Surgical Treatment
Publicado: (1941)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r48j7jive4rue18r4poqispj8j